Deadline To Comment On CMS' Proposed Rule Is Today

Published in Government Relations on August 29, 2025

VGM Group has submitted our comments on the CY26 CMS DMEPOS/Home Health Proposed Rule and encourages you to do the same (if you haven’t done so already)!  

Our comments provide key recommendations aimed at protecting patient access and supporting the HME community.  

VGM’s Key Recommendations Include:  

  • Opposing the proposed Remote Item Delivery Competitive Bid Program. 
  • Urging CMS to exclude ostomy, urological, and tracheostomy supplies from the bidding program. 
  • Advocating against the inclusion of liquid oxygen, diabetes products, and OTS upper-extremity braces in the program.
  • Retaining the bid ceiling at the unadjusted 2015 fee schedule. 
  • Preserving the current methodology for calculating the Single Payment Amount (SPA) using the clearing price.
  • Opposing the proposed shift to determine SPAs for lead items based on the 75th percentile of winning bids.

Your Voice Matters! — Submit Comments by Friday, Aug. 29, 11:59 p.m. ET. 

The proposed return of the Competitive Bidding Program and other proposed changes, as outlined, pose serious risks to the DMEPOS industry. With so much at stake, now is the time to make your voice heard!  

Submit Your Comments Here

Remember:  

  • Address the issues that matter most to your business. You don’t have to address every provision.  
  • Share how specific proposals affect your business, your employees, your patients, and the services you provide.  
  • Be factual and avoid PHI.  

You may find VGM’s comments here as a reference point. However, make sure to make them your own! Your experience, expertise, and perspective are the most persuasive to educate CMS on the impact of the proposed rules.  

From Our Experts

New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries thumbnail New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME), Cochairs of the Senate Diabetes Caucus, have introduced the Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act, S.4037. VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center thumbnail VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center VGM Government Relations is proud to announce the reintroduction of its Fraud, Waste & Abuse (FWA) Reporting Resource Center—a newly refreshed online hub designed to protect the integrity of the DMEPOS industry and reinforce our unwavering commitment to ethical, compliant care. Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical thumbnail Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical We're proud to once again recognize a true Champion of Change in the DME industry: Thom Harvill of Above and Beyond Medical in Tennessee. Thom has dedicated many years to the DME community—consistently showing up, speaking out, and pushing the industry forward. He's the kind of advocate who never stops asking, “Who else can I reach out to about this?” Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart.